We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBIX icon
676
Neurocrine Biosciences
NBIX
$18.2B
$1.18M 0.01%
10,261
-828
-7% -$114K
SFM icon
677
Sprouts Farmers Market
SFM
$7.44B
$1.17M 0.01%
10,568
-12,177
-54% -$1.16M
MKC icon
678
McCormick & Company Non-Voting
MKC
$14B
$1.15M 0.01%
14,026
-8
-0.1% -$624
PKG icon
679
Packaging Corp of America
PKG
$22.2B
$1.15M 0.01%
5,322
-1,405
-21% -$279K
FN icon
680
Fabrinet
FN
$14.9B
$1.14M 0.01%
4,835
-1,211
-20% -$280K
DECK icon
681
Deckers Outdoor
DECK
$14.1B
$1.14M 0.01%
7,161
+4,539
+173% +$692K
IAU icon
682
iShares Gold Trust
IAU
$62.8B
$1.14M 0.01%
22,861
+9,468
+71% +$443K
PRVA icon
683
Privia Health
PRVA
$3.04B
$1.13M 0.01%
61,927
-456
-0.7% -$8.7K
HDEF icon
684
Xtrackers MSCI EAFE High Dividend Yield Equity ETF
HDEF
$2.35B
$1.13M 0.01%
41,900
KEY icon
685
KeyCorp
KEY
$23.8B
$1.12M 0.01%
67,102
+8,399
+14% +$133K
VDC icon
686
Vanguard Consumer Staples ETF
VDC
$8.16B
$1.12M 0.01%
5,141
TXT icon
687
Textron
TXT
$14.9B
$1.12M 0.01%
12,641
-367
-3% -$32.4K
EEMV icon
688
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.36B
$1.12M 0.01%
17,838
-456
-2% -$27K
BOX icon
689
Box
BOX
$4.49B
$1.12M 0.01%
34,107
+535
+2% +$15.6K
PIPR icon
690
Piper Sandler
PIPR
$4.99B
$1.12M 0.01%
15,732
+2,180
+16% +$143K
LYB icon
691
LyondellBasell Industries
LYB
$19.5B
$1.12M 0.01%
11,628
+423
+4% +$40.5K
WHD icon
692
Cactus
WHD
$3.63B
$1.11M 0.01%
18,637
+80
+0.4% +$4.65K
TFX icon
693
Teleflex
TFX
$5.96B
$1.11M 0.01%
4,481
+249
+6% +$58.1K
VECO icon
694
Veeco
VECO
$2.62B
$1.1M 0.01%
33,143
+137
+0.4% +$5.13K
BF.B icon
695
Brown-Forman Class B
BF.B
$13.5B
$1.1M 0.01%
22,300
-4,903
-18% -$220K
SLG icon
696
SL Green Realty
SLG
$3.83B
$1.09M 0.01%
15,721
+2,337
+17% +$150K
CASH icon
697
Pathward Financial
CASH
$1.88B
$1.08M 0.01%
16,351
+4,335
+36% +$279K
RCL icon
698
Royal Caribbean
RCL
$86.8B
$1.08M 0.01%
6,080
+110
+2% +$17.8K
KDP icon
699
Keurig Dr Pepper
KDP
$42.8B
$1.07M 0.01%
28,593
+524
+2% +$18.4K
MIDD icon
700
Middleby
MIDD
$6.01B
$1.07M 0.01%
7,685
-324
-4% -$43.5K

Similar funds

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.